Search the GHTC website

Welcome to the first Research Roundup post. In this regular feature, we’ll highlight some of the most interesting reads in global health research from the past week.

January 5, 2012 by Emily Halnon

Welcome to the first Research Roundup post. In this regular feature, we’ll highlight some of the most interesting reads in global health research from the past week.

In this op-ed in the Huffington Post, Orin Levine, executive director of GHTC member organization the International Vaccine Access Center, draws a parallel between the development of the polio vaccine and the development of RTS,S—the most advanced malaria vaccine candidate that showed breakthrough results last week.

Chris Collins, vice president and director of public policy at GHTC member amfAR, argues in this op-ed that the US cannot afford to cut funding from foreign aid because it’s saving the lives of millions of people around the world.

The Food and Drug Administration (FDA) is launching two new Centers of Excellence in Regulatory Science and Innovation to promote the development of new medicines and medical devices. And the National Institutes of Health (NIH) is pushing for a new center to spur innovation and new technologies.

World Intellectual Property Organization (WIPO) and the World Health Organization (WHO) launch a new database to accelerate research for neglected diseases.

China and the Bill & Melinda Gates Foundation join forces to improve health innovations in developing countries. The partnership will support the manufacturing of new global health products, including vaccines and diagnostics.

About the author

Emily HalnonGHTC

Emily Halnon is a communications associate at GHTC.